美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	200623	001	NDA	LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	TABLET; ORAL	300MG; 300MG	No	No	2011/03/04 (TA)	--	CIPLA LIMITED	None (Tentative Approval)
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE	202171	001	NDA	LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE	TABLET; ORAL	300MG; 300MG; 200MG	No	No	2011/09/08 (TA)	--	MATRIX LABS LTD	None (Tentative Approval)
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	203283	001	NDA	LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	TABLET; ORAL	300MG; 300MG	No	No	2012/11/08 (TA)	--	MACLEODS PHARMS LTD	None (Tentative Approval)
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	202529	001	NDA	LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	TABLET; ORAL	300MG; 300MG	No	No	2013/05/17 (TA)	--	RANBAXY LABS LTD	None (Tentative Approval)
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE	204505	001	NDA	LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE	TABLET; ORAL	300MG; 300MG; 200MG	No	No	2013/10/18 (TA)	--	AUROBINDO PHARMA LTD	None (Tentative Approval)
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE	205355	001	NDA	LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE	TABLET; ORAL	300MG; 300MG; 200MG	No	No	2014/03/14 (TA)	--	HETERO LABS LTD III	None (Tentative Approval)
EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	205861	001	NDA	EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE	TABLET;ORAL	600MG;300MG;300MG	No	No	2014/08/14 (TA)	--	MACLEODS PHARMS LTD	None (Tentative Approval)
DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	210787	001	NDA	DOLUTEGRAVIR;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE	TABLET;ORAL	50MG; 300MG;300MG	No	No	2019/02/01 (TA)	--	LAURUS LABS LTD	None (Tentative Approval)
DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	210796	001	NDA	DOLUTEGRAVIR;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE	TABLET;ORAL	50MG/300MG/300MG	No	No	2019/03/25 (TA)	--	MACLEODS PHARMS LTD	None (Tentative Approval)
DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	211868	001	NDA	DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	TABLET;ORAL	50MG/300MG/300MG	No	No	2023/07/12 (TA)	--	EMCURE PHARMS LTD	None (Tentative Approval)